Petros Pharmaceuticals, Inc. (PTPI) Analyst Estimates Quarterly - Discounting Cash Flows
PTPI
Petros Pharmaceuticals, Inc.
PTPI (NASDAQ)
Period Ending: 2024
12-30
2024
09-30
2024
06-30
2024
03-30
2023
12-30
Number of Analysts 1 1 1 1 1
Estimated Revenue
Low 1.28 1.34 1.41 1.36 1.55
Average 1.28 1.34 1.42 1.39 1.55
High 1.28 1.34 1.43 1.42 1.55
Estimated EBITDA
Low -1.01 -1.06 -1.13 -1.12 -1.23
Average -1.01 -1.06 -1.12 -1.1 -1.23
High -1.01 -1.06 -1.11 -1.07 -1.23
Estimated EBIT
Low -1.28 -1.34 -1.43 -1.42 -1.55
Average -1.28 -1.34 -1.42 -1.39 -1.55
High -1.28 -1.34 -1.41 -1.36 -1.55
Estimated Net Income
Low -348.8 -306.6 -391.1 -1,787 -46.94
Average -348.8 -306.6 -391.1 -1,787 -46.94
High -348.8 -306.6 -391.1 -1,787 -46.94
Estimated SGA Expenses
Low 2.3 2.41 2.53 2.44 2.79
Average 2.3 2.41 2.55 2.49 2.79
High 2.3 2.41 2.57 2.55 2.79
Estimated EPS
Low -8.25 -7.25 -9.25 -42.25 -1.11
Average -8.25 -7.25 -9.25 -42.25 -1.11
High -8.25 -7.25 -9.25 -42.25 -1.11
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program